Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anthracycline Related Cardiotoxicity in Breast Cancer”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Large-scale testing (Phase 3)Study completedNCT03265574
What this trial is testing

PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma?

Who this might be right for
Breast CancerNon Hodgkin Lymphoma
South Tees Hospitals NHS Foundation Trust 111
Not applicableLooking for participantsNCT05467111
What this trial is testing

Cardioprotective Effect of Acute Exercise in Breast Cancer Patients

Who this might be right for
Early-stage Breast Cancer
Technical University of Madrid 40
Not applicableUnknownNCT03155802
What this trial is testing

Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines

Who this might be right for
CardiotoxicityHeart FailureBreast Cancer+3 more
Stony Brook University 35
Not applicableNot Yet RecruitingNCT06881940
What this trial is testing

Cardiac Rehabilitation Program on the Prevention of Cardiotoxicity in Breast Cancer Patients Undergoing Treatment With Anthracyclines and/or Trastuzumab

Who this might be right for
Cancer Therapy-Related Cardiac Dysfunction
Instituto Nacional de Cardiologia Ignacio Chavez 284
Not applicableActive Not RecruitingNCT03748550
What this trial is testing

Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2)

Who this might be right for
Cancer, BreastCardiotoxicityCardiovascular Diseases
Nova Scotia Health Authority 7
Testing effectiveness (Phase 2)Looking for participantsNCT03934905
What this trial is testing

Protective Effects of the Nutritional Supplement Sulforaphane on Doxorubicin-Associated Cardiac Dysfunction

Who this might be right for
Anthracycline Related Cardiotoxicity in Breast Cancer
Texas Tech University Health Sciences Center 70
Testing effectiveness (Phase 2)Looking for participantsNCT05732051
What this trial is testing

Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Breast CancerMetastatic Breast CancerCancer Therapy-Related Cardiac Dysfunction+2 more
University Hospital, Akershus 60
Post-approval studies (Phase 4)Looking for participantsNCT05465031
What this trial is testing

Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Who this might be right for
Breast CancerNeoplasm, BreastBreast Diseases+10 more
Silesian Centre for Heart Diseases 600
Not applicableEnded earlyNCT03089502
What this trial is testing

Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related Cardiotoxicity

Who this might be right for
Breast CancerLeft Ventricular DysfunctionHeart Failure, Systolic
University Health Network, Toronto 2
Post-approval studies (Phase 4)Study completedNCT04434404
What this trial is testing

Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy

Who this might be right for
Breast Cancer
Horus University 83
Not applicableLooking for participantsNCT06622954
What this trial is testing

Dietary Restriction to Prevent Cardiotoxicity in Breast Cancer Patients

Who this might be right for
CardiotoxicityBreast Cancer
Erasmus Medical Center 32
Not applicableNot Yet RecruitingNCT07426913
What this trial is testing

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

Who this might be right for
Breast CancerAnthracycline Related Cardiotoxicity in Breast CancerVirtual Reality+1 more
Virginia Commonwealth University 30
Not applicableStudy completedNCT03964142
What this trial is testing

Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced Cardiotoxicity

Who this might be right for
CardiotoxicityCardiac Rehabilitation
Hospital Clinico Universitario de Santiago 122
Not applicableEnded earlyNCT03850171
What this trial is testing

Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study

Who this might be right for
Breast Neoplasm FemaleLymphomaCardiotoxicity+2 more
Insel Gruppe AG, University Hospital Bern 57
Not applicableLooking for participantsNCT07191730
What this trial is testing

ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

Who this might be right for
CardiotoxicityHeart FailureNeoplasms+1 more
University Hospital, Caen 600
Not applicableStudy completedNCT02065908
What this trial is testing

Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer

Who this might be right for
Breast Cancer
West Pomeranian Cancer Center 128
Not applicableUnknownNCT05298072
What this trial is testing

Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients

Who this might be right for
CardiotoxicityBreast CancerHeart Failure
University Hospital, Essen 180
Not applicableNot Yet RecruitingNCT07070765
What this trial is testing

Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity

Who this might be right for
Breast Cancer
University of Aberdeen 70
Testing effectiveness (Phase 2)UnknownNCT06341842
What this trial is testing

Potential Protective Role of SGLT-2 Inhibitors for Chemotherapy-induced Cardiotoxicity

Who this might be right for
Breast Cancer
Fondazione IRCCS Policlinico San Matteo di Pavia 316
Post-approval studies (Phase 4)Not Yet RecruitingNCT07254221
What this trial is testing

Rosuvastatin for Prevention of Anthracycline-induced Cardiac Dysfunction in Breast Cancer Patients

Who this might be right for
Anthracycline-induced Cardiac ToxicityBreast CancerAnthracycline Related Cardiotoxicity in Breast Cancer+1 more
Shiraz University of Medical Sciences 400
Load More Results